Copyright © 2013 José M. Climent et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. G. Simons, “Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction,” Journal of Electromyography and Kinesiology, vol. 14, no. 1, pp. 95–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
2. K. A. Sluka, A. Kalra, and S. A. Moore, “Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia,” Muscle & Nerve, vol. 24, no. 1, pp. 37–46, 2001.
3. R. D. Gerwin, J. Dommerholt, and J. P. Shah, “An expansion of Simons' integrated hypothesis of trigger point formation,” Current pain and headache reports, vol. 8, no. 6, pp. 468–475, 2004. View at Scopus
4. T. S. Kuan, Y. C. Chang, and C. Z. Hong, “Distribution of active loci in rat skeletal muscle,” Journal of Musculoskeletal Pain, vol. 7, no. 4, pp. 45–54, 1999. View at Scopus
5. C. Z. Hong, “New trends in myofascial pain syndrome,” Chinese Medical Journal, vol. 65, no. 11, pp. 501–512, 2002. View at Scopus
6. D. G. Simons, C. Z. Hong, and L. S. Simons, “Endplate potentials are common to midfiber myofacial trigger points,” American Journal of Physical Medicine and Rehabilitation, vol. 81, no. 3, pp. 212–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
7. C. Z. Hong and D. G. Simons, “Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points,” Archives of Physical Medicine and Rehabilitation, vol. 79, no. 7, pp. 863–872, 1998. View at Publisher · View at Google Scholar · View at Scopus
8. J. P. Shah, T. M. Phillips, J. V. Danoff, and L. H. Gerber, “An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle,” Journal of Applied Physiology, vol. 99, no. 5, pp. 1977–1984, 2005. View at Publisher · View at Google Scholar · View at Scopus
9. J. P. Shah, J. V. Danoff, M. J. Desai et al., “Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points,” Archives of Physical Medicine and Rehabilitation, vol. 89, no. 1, pp. 16–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
10. S. Mense, “Muscle pain: mechanisms and clinical significance,” Deutsches Arzteblatt, vol. 105, no. 12, pp. 214–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
11. L. R. Watkins, M. R. Hutchinson, A. Ledeboer, J. Wieseler-Frank, E. D. Milligan, and S. F. Maier, “Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids,” Brain, Behavior, and Immunity, vol. 21, no. 2, pp. 131–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
12. M. F. Brin, “Botulinum toxin: chemistry, pharmacology, toxicity, and immunology,” Muscle and Nerve, vol. 20, supplement 6, pp. S146–S168, 1997. View at Scopus
13. J. Costa, C. Espírito-Santo, A. Borges et al., “Botulinum toxin type A therapy for cervical dystonia,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003633, 2005. View at Scopus
14. J. O. Dolly and K. R. Aoki, “The structure and mode of action of different botulinum toxins,” European Journal of Neurology, vol. 13, supplement 4, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
15. D. B. Lacy and R. C. Stevens, “Sequence homology and structural analysis of the clostridial neurotoxins,” Journal of Molecular Biology, vol. 291, no. 5, pp. 1091–1104, 1999. View at Publisher · View at Google Scholar · View at Scopus
16. Y. Aikawa, K. L. Lynch, K. L. Boswell, and T. F. J. Martin, “A second SNARE role for exocytic SNAP25 in endosome fusion,” Molecular Biology of the Cell, vol. 17, no. 5, pp. 2113–2124, 2006. View at Publisher · View at Google Scholar · View at Scopus
17. L. L. Simpson, A. B. Maksymowych, and S. Hao, “The role of zinc binding in the biological activity of botulinum toxin,” The Journal of Biological Chemistry, vol. 276, no. 29, pp. 27034–27041, 2001. View at Publisher · View at Google Scholar · View at Scopus
18. A. T. Brunger and A. Rummel, “Receptor and substrate interactions of clostridial neurotoxins,” Toxicon, vol. 54, no. 5, pp. 550–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
19. S. Mense, “Neurobiological basis for the use of botulinum toxin in pain therapy,” Journal of Neurology, Supplement, vol. 251, supplement 1, pp. I1–I7, 2004. View at Scopus
20. T. S. Kuan, J. T. Chen, S. M. Chen, C. H. Chien, and C. Z. Hong, “Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle,” American Journal of Physical Medicine and Rehabilitation, vol. 81, no. 7, pp. 512–520, 2002. View at Publisher · View at Google Scholar · View at Scopus
21. K. R. Aoki, “Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A,” NeuroToxicology, vol. 26, no. 5, pp. 785–793, 2005. View at Publisher · View at Google Scholar · View at Scopus
22. B. Jabbari, “Botulinum neurotoxins in the treatment of refractory pain,” Nature Clinical Practice Neurology, vol. 4, no. 12, pp. 676–685, 2008. View at Publisher · View at Google Scholar · View at Scopus
23. K. R. Aoki and J. Francis, “Updates on the antinociceptive mechanism hypothesis of botulinum toxin A,” Parkinsonism and Related Disorders, vol. 17, supplement 1, pp. S28–S33, 2011.
24. P. Gazerani, C. Staahl, A. M. Drewes, and L. Arendt-Nielsen, “The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization,” Pain, vol. 122, no. 3, pp. 315–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
25. W. P. Cheshire, S. W. Abashian, and J. D. Mann, “Botulinum toxin in the treatment of myofascial pain syndrome,” Pain, vol. 59, no. 1, pp. 65–69, 1994. View at Publisher · View at Google Scholar · View at Scopus
26. M. Ernberg, B. Hedenberg-Magnusson, T. List, and P. Svensson, “Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study,” Pain, vol. 152, no. 9, pp. 1988–1996, 2011.
27. J. De Andrés, V. M. Adsuara, S. Palmisani, V. Villanueva, and M. D. López-Alarcón, “A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans,” Regional Anesthesia and Pain Medicine, vol. 35, no. 3, pp. 255–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
28. K. Gül and A. S. Onal, “Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome,” Agri, vol. 21, no. 3, pp. 104–112, 2009. View at Scopus
29. R. A. De Venancio, F. G. P. Alencar, and C. Zamperini, “Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches,” Cranio, vol. 27, no. 1, pp. 46–53, 2009. View at Scopus
30. R. N. Harden, J. Cottrill, C. M. Gagnon et al., “Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study,” Headache, vol. 49, no. 5, pp. 732–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
31. C. Braker, S. Yariv, R. Adler, S. Badarny, and E. Eisenberg, “The analgesic effect of botulinum-toxin A on postwhiplash neck pain,” Clinical Journal of Pain, vol. 24, no. 1, pp. 5–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
32. H. L. Lew, E. H. Lee, A. Castaneda, R. Klima, and E. Date, “Therapeutic use of Botulinum Toxin Type A in treating neck and upper-back pain of Myofascial Origin: a pilot study,” Archives of Physical Medicine and Rehabilitation, vol. 89, no. 1, pp. 75–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
33. E. Qerama, A. Fuglsang-Frederiksen, H. Kasch, F. W. Bach, and T. S. Jensen, “A double-blind, controlled study of botulinum toxin A in chronic myofascial pain,” Neurology, vol. 67, no. 2, pp. 241–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
34. H. Göbel, A. Heinze, G. Reichel, H. Hefter, and R. Benecke, “Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study,” Pain, vol. 125, no. 1-2, pp. 82–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
35. T. Ojala, J. P. A. Arokoski, and J. Partanen, “The effect of small doses of botulinum toxin A on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial,” Clinical Journal of Pain, vol. 22, no. 1, pp. 90–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
36. C. L. Graboski, D. Shaun Gray, and R. S. Burnham, “Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study,” Pain, vol. 118, no. 1-2, pp. 170–175, 2005. View at Publisher · View at Google Scholar · View at Scopus
37. F. M. Ferrante, L. Bearn, R. Rothrock, and L. King, “Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A,” Anesthesiology, vol. 103, no. 2, pp. 377–383, 2005. View at Publisher · View at Google Scholar · View at Scopus
38. A. Kamanli, A. Kaya, O. Ardicoglu, S. Ozgocmen, F. O. Zengin, and Y. Bayik, “Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome,” Rheumatology International, vol. 25, no. 8, pp. 604–611, 2005. View at Publisher · View at Google Scholar · View at Scopus
39. A. M. Lang, “Botulinum Toxin Type B in Piriformis Syndrome,” American Journal of Physical Medicine and Rehabilitation, vol. 83, no. 3, pp. 198–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
40. J. De Andrés, G. Cerda-Olmedo, J. C. Valía, V. Monsalve, Lopez-Alarcón, and A. Minguez, “Use of botulinum toxin in the treatment of chronic myofascial pain,” Clinical Journal of Pain, vol. 19, no. 4, pp. 269–275, 2003. View at Publisher · View at Google Scholar · View at Scopus
41. L. Foster, L. Clapp, M. Erickson, and B. Jabbari, “Botulinum toxin A and chronic low back pain a randomized, double-blind study,” Neurology, vol. 56, no. 10, pp. 1290–1293, 2001. View at Scopus
42. L. M. Fishman, C. Anderson, and B. Rosner, “BOTOX and physical therapy in the treatment of piriformis syndrome,” American Journal of Physical Medicine and Rehabilitation, vol. 81, no. 12, pp. 936–942, 2002. View at Publisher · View at Google Scholar · View at Scopus
43. M. Porta, “A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm,” Pain, vol. 85, no. 1-2, pp. 101–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
44. A. H. Wheeler, P. Goolkasian, and S. S. Gretz, “A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome,” Spine, vol. 23, no. 15, pp. 1662–1667, 1998. View at Publisher · View at Google Scholar · View at Scopus
45. R. Gerwin, “Botulinum toxin treatment of myofascial pain: a critical review of the literature,” Current Pain and Headache Reports, vol. 16, no. 5, pp. 413–422, 2012.
46. A. Soares, R. B. Andriolo, A. N. Atallah, and E. M. K. Da Silva, “Botulinum toxin for myofascial pain syndromes in adults,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD007533, 2009.
47. T. Zhang, A. Adatia, W. Zarin et al., “The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis,” Inflammopharmacology, vol. 19, no. 1, pp. 21–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
48. E. Qerama, A. Fuglsang-Frederiksen, and T. S. Jensen, “The role of botulinum toxin inmanagement of pain: an evidence-based review,” Current Opinion in Anesthesiology, vol. 23, no. 5, pp. 602–610, 2010.
49. O. C. Colhado, M. Boeing, and L. B. Ortega, “Botulinum toxin in pain treatment,” Revista Brasileira de Anestesiologia, vol. 59, no. 3, pp. 366–381, 2009.
50. K. Y. Ho and K. H. Tan, “Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review,” European Journal of Pain, vol. 11, no. 5, pp. 519–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
51. C. A. Pereda, J. Usón Jaeger, and L. Carmona, “Systematic review: can botulinum toxin be recommended as treatment for pain in myofascial syndrome?” Reumatologia Clinica, vol. 2, no. 4, pp. 173–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
52. P. Reilich, K. Fheodoroff, U. Kern et al., “Consensus statement: botulinum toxin in myofacial pain,” Journal of Neurology, vol. 251, supplement 1, pp. I36–I38, 2004. View at Scopus
53. A. M. Lang, “Botulinum toxin type A therapy in chronic pain disorders,” Archives of Physical Medicine and Rehabilitation, vol. 84, no. 3, Supplement 1, pp. S69–S73, 2003.
54. P. Langevin, P. M. Peloso, J. Lowcock et al., “Botulinum toxin for subacute/chronic neck pain,” Cochrane Database of Systematic Reviews, no. 7, Article ID CD008626, 2011. View at Scopus
55. Z. Waseem, C. Boulias, A. Gordon, F. Ismail, G. Sheean, and A. D. Furlan, “Botulinum toxin injections for low-back pain and sciatica,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD008257, 2011. View at Scopus
56. B. Jabbari and D. Machado, “Treatment of refractory pain with botulinum toxins-an evidence-based review,” Pain Medication, vol. 12, no. 11, pp. 1594–1606, 2011.
57. M. Naumann, Y. So, C. E. Argoff et al., “Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology,” Neurology, vol. 70, no. 19, pp. 1707–1714, 2008. View at Publisher · View at Google Scholar · View at Scopus
58. N. A. Scott, B. Guo, P. M. Barton, and R. D. Gerwin, “Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review,” Pain Medicine, vol. 10, no. 1, pp. 54–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
59. J. J. Ferreira, M. Couto, J. Costa, M. Coelho, M. M. Rosa, and C. Sampaio, “Botulinum toxin for the treatment of pain syndromes,” Acta reumatológica portuguesa, vol. 31, no. 1, pp. 49–62, 2006. View at Scopus
60. R. D. Gerwin, S. Shannon, C. Z. Hong, D. Hubbard, and R. Gevirtz, “Interrater reliability in myofascial trigger point examination,” Pain, vol. 69, no. 1-2, pp. 65–73, 1997. View at Publisher · View at Google Scholar · View at Scopus
61. S. Sikdar, J. P. Shah, T. Gebreab et al., “Novel applications of ultrasound technology to visualize and characterize myofascial trigger points (MTrPs) and surrounding soft tissue,” Archives of Physical Medicine and Rehabilitation, vol. 90, pp. 1829–1838, 2009.
62. E. A. Tough, A. R. White, S. Richards, and J. Campbell, “Variability of criteria used to diagnose myofascial trigger point pain syndrome—evidence from a review of the literature,” Clinical Journal of Pain, vol. 23, no. 3, pp. 278–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
63. C. R. Hou, L. C. Tsai, K. F. Cheng, K. C. Chung, and C. Z. Hong, “Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger-point sensitivity,” Archives of Physical Medicine and Rehabilitation, vol. 83, no. 10, pp. 1406–1414, 2002. View at Publisher · View at Google Scholar · View at Scopus
64. R. D. Gerwin, “Classification, epidemiology, and natural history of myofascial pain syndrome,” Current Pain and Headache Reports, vol. 5, no. 5, pp. 412–420, 2001. View at Scopus
65. B. J. Freund and M. Schwartz, “Erratum: Treatment of whiplash associated with neck pain with botulinum toxin-A: a pilot study,” Journal of Rheumatology, vol. 27, no. 6, p. 1577, 2000. View at Scopus
66. H. Shankar and C. Cummings, “Ultrasound imaging of embedded shrapnel facilitates diagnosis and management of myofascial pain syndrome,” Pain Practice, 2012. View at Publisher · View at Google Scholar
67. B. Jabbari, J. Ney, A. Sichani, W. Monacci, L. Foster, and M. Difazio, “Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study,” Pain Medicine, vol. 7, no. 3, pp. 260–264, 2006. View at Publisher · View at Google Scholar · View at Scopus
68. C. Z. Hong, “Lidocaine injection versus dry needling to myofascial trigger point: the importance of the local twitch response,” American Journal of Physical Medicine and Rehabilitation, vol. 73, no. 4, pp. 256–263, 1994. View at Publisher · View at Google Scholar · View at Scopus
69. S. H. Yoon, U. W. Rah, S. S. Sheen, and K. H. Cho, “Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial,” Archives of Physical Medicine and Rehabilitation, vol. 90, no. 8, pp. 1332–1339, 2009. View at Publisher · View at Google Scholar · View at Scopus
70. A. E. Sola and J. H. Kuitert, “Myofascial trigger point pain in the neck and shoulder girdle,” Northwest Medicine, vol. 54, pp. 980–984, 1955.
71. A. E. Sola and R. L. Williams, “Myofascial pain syndromes,” Neurology, vol. 6, pp. 91–95, 1956.
72. F. A. Frost, B. Jessen, and J. Siggaard-Andersen, “A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain,” The Lancet, vol. 1, no. 8167, pp. 499–500, 1980. View at Scopus
73. P. Tfelt Hansen, I. Lous, and J. Olesen, “Prevalence and significance of muscle tenderness during common migraine attacks,” Headache, vol. 21, no. 2, pp. 49–54, 1981. View at Scopus
74. K. Lewit, “The needle effect in the relief of myofascial pain,” Pain, vol. 6, no. 1, pp. 83–90, 1979. View at Publisher · View at Google Scholar · View at Scopus
75. P. Baldry, “Management of myofascial trigger point pain,” Acupuncture in Medicine, vol. 20, no. 1, pp. 2–10, 2002. View at Scopus
76. D. Miller, D. Richardson, M. Eisa, R. J. Bajwa, and B. Jabbari, “Botulinum neurotoxin-a for treatment of refractory neck pain: a randomized, double-blind study,” Pain Medicine, vol. 10, no. 6, pp. 1012–1017, 2009. View at Publisher · View at Google Scholar · View at Scopus
77. L. C. Jeynes and C. A. Gauci, “Evidence for the use of botulinum toxin in the chronic pain setting—a review of the literature,” Pain Practice, vol. 8, no. 4, pp. 269–276, 2008. View at Publisher · View at Google Scholar · View at Scopus